AR132909A1 - METHODS OF TREATMENT OF INFLAMMATORY DISEASES - Google Patents
METHODS OF TREATMENT OF INFLAMMATORY DISEASESInfo
- Publication number
- AR132909A1 AR132909A1 ARP240101472A ARP240101472A AR132909A1 AR 132909 A1 AR132909 A1 AR 132909A1 AR P240101472 A ARP240101472 A AR P240101472A AR P240101472 A ARP240101472 A AR P240101472A AR 132909 A1 AR132909 A1 AR 132909A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- pharmaceutically acceptable
- treatment
- inflammatory diseases
- formula
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente divulgación se refiere a compuestos de fórmula (1), como se define en el presente documento, y sus sales farmacéuticamente aceptables, y composiciones que los comprenden. También se describen métodos para tratar las enfermedades y trastornos descritos en el presente documento, con los compuestos de fórmula (1) y sus sales farmacéuticamente aceptables, y las composiciones que los comprenden. Un compuesto de fórmula (1). Una composición farmacéutica que comprende un compuesto de cualquiera de las reivindicaciones 1 - 18, o una sal farmacéuticamente aceptable del mismo, y uno o más excipientes farmacéuticamente aceptables.The present disclosure relates to compounds of formula (1), as defined herein, and their pharmaceutically acceptable salts, and compositions comprising them. Also described are methods of treating the diseases and disorders described herein, with the compounds of formula (1) and their pharmaceutically acceptable salts, and compositions comprising them. A compound of formula (1). A pharmaceutical composition comprising a compound of any one of claims 1-18, or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063472252P | 2020-06-09 | 2020-06-09 | |
| US202363609168P | 2023-12-12 | 2023-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR132909A1 true AR132909A1 (en) | 2025-08-06 |
Family
ID=96877974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240101472A AR132909A1 (en) | 2020-06-09 | 2024-06-10 | METHODS OF TREATMENT OF INFLAMMATORY DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR132909A1 (en) |
-
2024
- 2024-06-10 AR ARP240101472A patent/AR132909A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR128931A1 (en) | COMPLEMENT B FACTOR INHIBITORS AND USES THEREOF | |
| CO2019009423A2 (en) | Piperidine Substituted MNK Inhibitors and Related Methods | |
| MX2021011606A (en) | Compounds targeting prmt5. | |
| ECSP20069418A (en) | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | |
| CL2022000271A1 (en) | Pyrazolo(3,4-b)pyrazine shp2 phosphatase inhibitors. | |
| CL2022001739A1 (en) | Substituted tricyclic compounds | |
| CO2021015318A2 (en) | Compounds and methods for the treatment of covid-19 | |
| DOP2024000039A (en) | QUINOLINE DERIVATIVES AS ALFA4BETA7 INTEGRIN INHIBITORS | |
| CL2022001741A1 (en) | Cyclic compounds and methods of using same | |
| CL2024001022A1 (en) | Small molecules for cancer treatment | |
| AR105808A1 (en) | AMIDA COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS | |
| AR127470A1 (en) | LRRK2 INHIBITORS | |
| CO2021014210A2 (en) | Pyrrole compounds | |
| UY39181A (en) | COMPOUNDS AND COMPOSITIONS FOR INHIBITING HIF2a ACTIVITY AND THEIR METHODS OF USE | |
| MX2019006612A (en) | IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS. | |
| MX2025010799A (en) | Acylsulfonamide kat6a inhibitors | |
| AR133953A1 (en) | COMPLEMENT FACTOR B INHIBITORS AND THEIR USES | |
| CO2025003099A2 (en) | Compounds for cancer treatment | |
| AR126892A1 (en) | SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | |
| UY37745A (en) | BICYCLIC COMPOUNDS 5.6 FUSIONATES AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES | |
| AR132909A1 (en) | METHODS OF TREATMENT OF INFLAMMATORY DISEASES | |
| DOP2021000100A (en) | CYCLIC TETRAMEROUS COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS. | |
| MX2021012544A (en) | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF KIDNEY DISEASES. | |
| AR128100A1 (en) | COMPOUNDS FOR THE TREATMENT OF HAIR LOSS | |
| MX2024009581A (en) | N3-substituted uracil compounds as trpa1 inhibitors. |